Skip to main content

Xolair News

AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies

MONDAY, Feb. 26, 2024 – Omalizumab treatment for 16 weeks is superior to placebo for increasing the reaction threshold for peanut and other food allergens among persons with multiple food allergies,...

Asthma Drug Xolair Guards Against Severe Reactions in People With Food Allergies

MONDAY, Feb. 26, 2024 – The asthma medication Xolair has proved its prowess against food allergies, with new research showing the medication substantially lowers the chances of severe reactions in...

FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies

South San Francisco, CA – February 16, 2024 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved...

FDA Expands Use of Asthma Med Xolair to Treat Food Allergies

FRIDAY, Feb. 16, 2024 – People threatened by accidental exposure to foods they're allergic to may have a new weapon of defense: On Friday, the U.S. Food and Drug Administration expanded the use of...

Expanded Use of Xolair to Treat Food Allergies Approved by the FDA

FRIDAY, Feb. 16, 2024 – The U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions. Xolair is an injected drug and is...

Injected Xolair Therapy Could Prevent Food Allergies in Kids

THURSDAY, Dec. 21, 2023 – A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results. A lab-made monoclonal antibody called omalizumab...

Injected Xolair Therapy Could Prevent Food Allergies in Kids

THURSDAY, Dec. 21, 2023 – A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results. A lab-made monoclonal antibody called omalizumab...

Many Primary Care Docs Unaware of Biologic Asthma Meds

TUESDAY, Nov. 21, 2023 – Biologic drugs to treat asthma have been around for two decades, but a surprising number of family doctors still aren’t prescribing them to kids and adults. A new survey f...

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

South San Francisco, CA – April 12, 2021 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the...

Genentech Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal Polyps

South San Francisco, CA – December 1, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the...

FDA Approves Genentech’s Xolair (omalizumab) for Allergic Asthma in Children

South San Francisco, CA – July 7, 2016 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Xolair...

FDA Medwatch Alert: Xolair (omalizumab): Drug Safety Communication - Slightly Elevated Risk of Cardiovascular and Cerebrovascular Serious Adverse Events

ISSUE: An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug...

FDA Approves Xolair (omalizumab) for Chronic Idiopathic Urticaria

South San Francisco, Calif. – March 21, 2014 – Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) for the...

FDA Medwatch Alert: Xolair (omalizumab)

Indications and Usage: for treatment of adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Urticaria, Hives, Asthma, Asthma - Maintenance, Nasal Polyps

Xolair patient information at Drugs.com